Safety and immunogenicity of a revaccination with a respiratory syncytial virus prefusion F vaccine in older adults: a phase 2b study
I Leroux-Roels, M Van Ranst… - The Journal of …, 2024 - academic.oup.com
Background In the previous (parent) study, 2 doses of different formulations of an
investigational vaccine against respiratory syncytial virus (RSVPreF3 OA) were well …
investigational vaccine against respiratory syncytial virus (RSVPreF3 OA) were well …
Immunogenicity, Reactogenicity, and Safety of AS01E-adjuvanted Respiratory Syncytial Virus (RSV) Prefusion F Protein-based Candidate Vaccine (RSVPreF3 OA) …
R Chandler, N Montenegro, C Llorach… - Clinical Infectious …, 2024 - academic.oup.com
Background Co-administration of vaccines against respiratory syncytial virus (RSV) and
influenza can be considered given their overlapping seasonality and may increase vaccine …
influenza can be considered given their overlapping seasonality and may increase vaccine …